Symptomatic Treatment of MS - European Multiple Sclerosis Platform
Symptomatic Treatment of MS - European Multiple Sclerosis Platform
Symptomatic Treatment of MS - European Multiple Sclerosis Platform
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
plegia: a review <strong>of</strong> effectiveness studies. J Rehabil Med 35:2-7<br />
189. Padma-Nathan H, Hellstrom WJ, Kaiser FE, Labasky RF, Lue TF, Nolten WE, Norwood PC, Peterson<br />
CA, Shabsigh R, Tam PY (1997) <strong>Treatment</strong> <strong>of</strong> men with erectile dysfunction with transurethral<br />
alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med 336:1-7<br />
190. Paisley S, Beard S, Hunn A, Wight J (2002) Clinical effectiveness <strong>of</strong> oral treatments for spasticity in<br />
multiple sclerosis: a systematic review. Mult Scler 8:319-329<br />
191. Park RH, Allison MC, Lang J, Spence E, Morris AJ, Danesh BJ, Russell RI, Mills PR (1992) Randomised<br />
comparison <strong>of</strong> percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients<br />
with persisting neurological dysphagia. BMJ 304:1406-1409<br />
192. Patti F, Ciancio MR, Reggio E, Lopes R, Palermo F, Cacopardo M, Reggio A (2002) The impact <strong>of</strong><br />
outpatient rehabilitation on quality <strong>of</strong> life in multiple sclerosis. J Neurol 249:1027-1033<br />
193. Patwardhan, RV, Minagar A, Kelley RE, Nanda A (2006) Neurosurgical treatment in multiple sclerosis.<br />
Neurol Res 28: 320-325<br />
194. Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, Kroin JS (1989) Intrathecal bacl<strong>of</strong>en<br />
for severe spinal spasticity. N Engl J Med 320:1517-1521<br />
195. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW (1996) Impact <strong>of</strong> aerobic<br />
training on fitness and quality <strong>of</strong> life in multiple sclerosis. Ann Neurol 39:432-441<br />
196. Philadelphia Panel (2001) Philadelphia Panel evidence-based clinical practice guidelines on<br />
selected rehabilitation interventions for shoulder pain. Phys Ther 81:1719-1730<br />
197. Philadelphia Panel (2001) Philadelphia Panel evidence-based clinical practice guidelines on<br />
selected rehabilitation interventions for low back pain. Phys Ther 81:1641-1674<br />
198. Pliskin NH, Hamer DP, Goldstein DS, Towle VL, Reder AT, Noronha A, Arnason BG (1996) Improved<br />
delayed visual reproduction test performance in multiple sclerosis patients receiving interferon<br />
beta-1b. Neurology 47:1463-1468<br />
199. Plohmann AM, Kappos L, Ammann W, Thordai A, Wittwer A, Huber S, Bellaiche Y, Lechner-Scott J<br />
(1998) Computer assisted retraining <strong>of</strong> attentional impairments in patients with multiple sclerosis.<br />
J Neurol Neurosurg Psychiatry 64:455-462<br />
200. Polman CH, Bertelsmann FW, de Waal R, van Diemen HA, Uitdehaag BM, van Loenen AC, Koetsier<br />
JC (1994) 4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment <strong>of</strong> patients with<br />
multiple sclerosis. Arch Neurol 51:1136-1139<br />
201. PRIS<strong>MS</strong> (Prevention <strong>of</strong> Relapses and Disability by Interferon beta-1a subcutaneously in <strong>Multiple</strong><br />
<strong>Sclerosis</strong>) Study Group (1998) Randomised double-blind placebo-controlled study <strong>of</strong> Interferon<br />
beta-1a in relapsing-remitting multiple sclerosis. Lancet 352:1498-1504<br />
202. Prosiegel M, Schleicher M, Yassouridis Y (1999) Success <strong>of</strong> rehabilitation and predictors <strong>of</strong><br />
outcome in patients with neurogenic dysphagia. Zentralbl Neurochir 58:47-48<br />
E<strong>MS</strong>P, <strong>Symptomatic</strong> <strong>Treatment</strong> <strong>of</strong> <strong>Multiple</strong> <strong>Sclerosis</strong>, December 2006 - revised in April 2008 54
Change language